[Clinical study, in Morocco, on Ciba 32644-Ba (amebiasis and bilhariasis)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000562:Amebiasis / Q000188:drug therapy*; D000871:Anthelmintics / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D012552:Schistosomiasis / Q000188:drug therapy*; D014581:Urticaria / Q000209:etiology; D014839:Vomiting / Q000209:etiology
D000871:Anthelmintics
Etude clinique au Maroc du Ciba 32644-Ba (amibiase et bilharziose)